Autolus Therapeutics plc


Autolus Therapeutics plc Website Screenshot

http://www.autolus.com

Autolus Therapeutics plc Company Intro

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of hematological malignancies and solid tumors. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 for the treatment of multiple myeloma; AUTO4 and AUTO 5 for T cell lymphoma; and AUTO6 and AUTO7 to treat solid tumors. The company was founded in 2014 and is headquartered in London, the United Kingdom.

Industry

Healthcare

Autolus Therapeutics plc Headquaters

Forest House
London,W12 7RZ
United Kingdom


Autolus Therapeutics plc Share price

17 May 2023 12:49 GMT

$2.4700

-0.05 (-1.98 %)


Autolus Therapeutics plc Market cap

$427.495 M


WMC RANKING

2024

Autolus Therapeutics plc # 257

Biotechnology

Latest Autolus Therapeutics plc News

News 12 Feb 2024

Analyst Expresses Confidence in Autolus Therapeutics with Increased Price Target

On February 12, 2024, Gil Blum, an esteemed analyst at Needham, expressed his confidence in Autolus Therapeutics (NASDAQ:AUTL) by maintaining a Buy rating.

News 12 Feb 2024

Autolus Therapeutics (NASDAQ:AUTL) PT Raised to $9.00

Needham & Company LLC increased their price target on shares of Autolus Therapeutics from $8.00 to $9.00 and gave the stock a "buy" rating in a research...

News 12 Feb 2024

Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up on Analyst Upgrade

Autolus Therapeutics plc (NASDAQ:AUTL - Get Free Report)'s stock price gapped up before the market opened on Monday after Needham & Company LLC raised their...


WMC Market Score


WMC Market to Revenue Score


Autolus Therapeutics plc Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Autolus Therapeutics plc USD $1,646 $170,428 $-145,487 $4,275M 257
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $804,390B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $878,880B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $144,340B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Autolus Therapeutics plc Social Followers vs Top 4 Industry Competitors



Autolus Therapeutics plc Post vs Top 4 Industry Competitors




Autolus Therapeutics plc Digital Footprint By Size vs Top 4 Industry Competitors



Autolus Therapeutics plc Digital Footprint By Change Rate vs Top 4 Industry Competitors



Autolus Therapeutics plc WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Autolus Therapeutics plc 0.02 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 28 0 0 29.94
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 40 0 0 36.32
Alexion Pharmaceuticals, Inc. 68.08 100 100 32 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 45.31

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries